CopyMark Law Group
4.9/5
Drawing for PHARMAPREMIA

USPTO serial 87556997

PHARMAPREMIA

Reviewed by CopyMark Law Group

Reg. 5412791Status 702Registered
Filing date
Status date
Registration date
Feb 27, 2018
Examiner
DELGIZZI, RONALD ERNEST
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with PHARMAPREMIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William C. Wright

William C. Wright Epstein Drangel LLP60 East 42nd Street, Suite 1250New York, NY 10165United States

Goods and services

ClassDescriptionStatusFirst use
042Providing a website featuring on-line non-downloadable software in the nature of an analytical tool that assesses the potential success rates of pharmaceutical clinical trials and regulatory approvalsACTIVENov 7, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 7, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 7, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 7, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 21, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Jul 17, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 17, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 17, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 17, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 17, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 7, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 27, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 13, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 13, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 27, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 12, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 12, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 6, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 6, 2017DOCKASSIGNED TO EXAMINER—
Aug 9, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 8, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance